Advertisement

Topics

NCCN releases updated guidelines on use of NSCLC drugs

06:06 EDT 25 Mar 2019 | SmartBrief

The National Comprehensive Cancer Network has updated the guidelines on the use of non-small cell lung cancer immunotherapies -More

Original Article: NCCN releases updated guidelines on use of NSCLC drugs

NEXT ARTICLE

More From BioPortfolio on "NCCN releases updated guidelines on use of NSCLC drugs"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Gilotrif (afatinib)
GILOTRIF (afatinib) is a kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L8...